Catherine Williamson

ORCID: 0000-0002-6226-7611
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug Transport and Resistance Mechanisms
  • Pediatric Hepatobiliary Diseases and Treatments
  • Pregnancy and Medication Impact
  • Pregnancy and preeclampsia studies
  • Liver Disease Diagnosis and Treatment
  • Birth, Development, and Health
  • Liver Diseases and Immunity
  • Reproductive System and Pregnancy
  • Pharmacological Effects and Toxicity Studies
  • Pancreatitis Pathology and Treatment
  • Gestational Diabetes Research and Management
  • Cholesterol and Lipid Metabolism
  • Liver Disease and Transplantation
  • Pituitary Gland Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Hepatitis B Virus Studies
  • Adipose Tissue and Metabolism
  • Trace Elements in Health
  • Growth Hormone and Insulin-like Growth Factors
  • Metabolism and Genetic Disorders
  • Hormonal Regulation and Hypertension
  • Genetic Syndromes and Imprinting
  • Fatty Acid Research and Health
  • Parathyroid Disorders and Treatments
  • Hypothalamic control of reproductive hormones

King's College London
2016-2025

Imperial College London
2012-2025

Hammersmith Hospital
2006-2024

Guy's and St Thomas' NHS Foundation Trust
2011-2024

The Tavistock and Portman NHS Foundation Trust
2024

Society of Thoracic Surgeons
2022

University College London
2014-2022

Lithuanian University of Health Sciences
2019-2021

St Thomas' Hospital
2003-2021

Bendigo Health
2021

In the triennium 2006-2008, 261 women in UK died directly or indirectly related to pregnancy.The overall maternal mortality rate was 11.39 per 100,000 maternities.Direct deaths decreased from 6.24 maternities 2003-2005 4.67 2006-2008 (p = 0.02).This decline is predominantly due reduction thromboembolism and, a lesser extent, haemorrhage.For first time there has been inequalities gap, with significant decrease rates among those living most deprived areas and lowest socio-economic...

10.1111/j.1471-0528.2010.02847.x article EN BJOG An International Journal of Obstetrics & Gynaecology 2011-03-01

The calcium-sensing receptor regulates the secretion of parathyroid hormone in response to changes extracellular calcium concentrations, and mutations that result a loss function are associated with familial hypocalciuric hypercalcemia. Mutations involving gain have been hypocalcemia two kindreds. We examined possibility latter type mutation may phenotype hypercalciuria.

10.1056/nejm199610103351505 article EN New England Journal of Medicine 1996-10-10
Ernest Turro William J. Astle Karyn Mégy Stefan Gräf Daniel Greene and 95 more Olga Shamardina Hana Lango Allen Alba Sanchis‐Juan Mattia Frontini Chantal Thys Jonathan Stephens Rutendo Mapeta Oliver S. Burren Kate Downes Matthias Haimel Salih Tuna Sri V. V. Deevi Timothy J. Aitman David Bennett Paul Calleja Keren Carss Mark J. Caulfield Patrick F. Chinnery Peter H. Dixon Daniel P. Gale Roger James Ania Koziell Michael Laffan Adam P. Levine Eamonn R. Maher Hugh S. Markus Joannella Morales Nicholas W. Morrell Andrew Mumford Elizabeth Ormondroyd Stuart Rankin Augusto Rendon Sylvia Richardson Irene Roberts Noémi Roy Moin A. Saleem Kenneth G. C. Smith Hannah Stark Rhea Tan Andreas C. Themistocleous Adrian J. Thrasher Hugh Watkins Andrew R. Webster Martin R. Wilkins Catherine Williamson James Whitworth Sean Humphray David Bentley Stephen Abbs Lara Abulhoul Julian Adlard Munaza Ahmed Timothy J. Aitman Hana Alachkar David Allsup J. P. Almeida Philip Ancliff Richard Antrobus Ruth Armstrong Gavin Arno Sofie Ashford William J. Astle Anthony Attwood Paul Aurora Christian Babbs Chiara Bacchelli Tamam Bakchoul Siddharth Banka Tadbir K. Bariana Julian Barwell Joana Batista Helen Baxendale Phil Beales David Bennett David Bentley Agnieszka Bierżyńska Tina Biss Maria Bitner‐Glindzicz Graeme Black Marta Bleda Iulia Blesneac Detlef Böckenhauer Harm Jan Bogaard Christian Bourne Sara Boyce John R. Bradley Eugene Bragin Gerome Breen Paul Brennan Carole Brewer Matthew A. Brown Andrew C. Browning Michael J. Browning Rachel Buchan Matthew Buckland

10.1038/s41586-020-2434-2 article EN Nature 2020-06-24

Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disease, characterized by maternal pruritus and raised serum bile acids. Our objectives were to describe the epidemiology complications associated with severe ICP test hypothesis that adverse perinatal outcomes are increased in these women. A prospective population-based case-control study national coverage was undertaken using UK Obstetric Surveillance System (UKOSS). Control data for comparison obtained from women...

10.1002/hep.26617 article EN cc-by-nc-nd Hepatology 2013-07-15

Intrahepatic cholestasis of pregnancy, characterised by maternal pruritus and increased serum bile acid concentrations, is associated with rates stillbirth, preterm birth, neonatal unit admission. Ursodeoxycholic widely used as a treatment without an adequate evidence base. We aimed to evaluate whether ursodeoxycholic reduces adverse perinatal outcomes in women intrahepatic pregnancy.We did double-blind, multicentre, randomised placebo-controlled trial at 33 hospital maternity units England...

10.1016/s0140-6736(19)31270-x article EN cc-by The Lancet 2019-08-01
Wei Wei Salih Tuna Michael J. Keogh Katherine R. Smith Timothy J. Aitman and 95 more Phil L. Beales David Bennett Daniel P. Gale Maria Bitner‐Glindzicz Graeme Black Paul Brennan Perry Elliott Frances Flinter R. Andres Floto Henry Houlden Melita Irving Ania Koziell Eamonn R. Maher Hugh S. Markus Nicholas W. Morrell William G. Newman Irene Roberts John A. Sayer Kenneth G. C. Smith Jenny C. Taylor Hugh Watkins Andrew R. Webster Andrew O.M. Wilkie Catherine Williamson Sofie Ashford Christopher J. Penkett Kathleen Stirrups Augusto Rendon Willem H. Ouwehand John R. Bradley F. Lucy Raymond Mark J. Caulfield Ernest Turro Patrick F. Chinnery Aarnoud Huissoon Abigail Crisp-Hihn Adam Shaw Adam J. Mead Adam P. Levine Adrian J. Thrasher Agnieszka Bierżyńska Ahamad Hassan Ajith Kumar Alba Sanchis‐Juan Alex Richter Allan Lawrie Amy Frary Andrea H. Németh Andrea Olschewski Andreas C. Themistocleous Andrew C. Browning Andrew Mumford Andrew M. Schaefer Andrew Marshall Andrew O.M. Wilkie Andrew Peacock Andrew R. Harper Andrew R. Webster Andrew S.C. Rice Angela Pyle Ania Koziell Anna M. Drazyk Anne M. Kelly Annette Wagner Anthony Attwood Anthony De Soyza Anthony M. Vandersteen Anthony T. Moore Anton Vonk Noordegraaf Anupama Rao Archana Herwadkar Arjan C. Houweling Arjune Sen Augusto Rendon Austen Worth Barbara Girerd Bella Madan Brian T. Wilson Carmen Bugarin Diz Carmen Treacy Carole Brewer Carolyn Campbell Carolyn M. Millar Catherine Roughley Catherine Titterton Catherine Williamson Cecilia Compton Cesare Danesino Chantal Thys Charaka Hadinnapola Charu Deshpande Cheng‐Hock Toh Chris Van Geet Christian Babbs C. Geoffrey Woods

Heteroplasmy incidence in mitochondrial DNA In humans, (mtDNA) is predominantly maternally inherited. mtDNA under selection to prevent heteroplasmy—the transmission of multiple genetic variants into the next generation. Wei et al. explored human sequences determine genome structure, selection, and transmission. Whole-genome sequencing revealed that about 45% individuals carry heteroplasmic at levels greater than 1% their total mtDNA. Furthermore, studies more 1500 mother-offspring pairs...

10.1126/science.aau6520 article EN Science 2019-05-23

Intrahepatic cholestasis of pregnancy (ICP) is a liver disease with serious consequences for the mother and fetus. Two pedigrees have been reported ICP in mothers children subtype autosomal recessive progressive familial intrahepatic (PFIC) raised serum γ‐glutamyl transpeptidase (γ-GT). Affected homozygous mutations MDR3 gene (also called ABCB4), heterozygous ICP. More frequently, however, occurs women no known family history PFIC genetic basis this disorder unknown. We investigated eight...

10.1093/hmg/9.8.1209 article EN Human Molecular Genetics 2000-05-01

Objective To explore the clinical features of obstetric cholestasis pregnancies in UK white Caucasians. Design A questionnaire survey. Setting Study coordinated at Queen Charlotte's Hospital. Population Clinical 352 affected 227 Caucasian women identified via a patient support group. Methods Evaluation gestation which prematurity and intrauterine death occur, recording additional complicated by cholestasis. Main outcome measures The timing prematurity. Results Among pregnancies, 23 (7%) were...

10.1111/j.1471-0528.2004.00167.x article EN BJOG An International Journal of Obstetrics & Gynaecology 2004-05-21

<h3>Background:</h3> Intrahepatic cholestasis of pregnancy (ICP) has a complex aetiology with significant genetic component. <i>ABCB11</i> encodes the bile salt export pump (BSEP); mutations cause spectrum cholestatic disease, and are implicated in ICP. <h3>Methods:</h3> variation ICP was investigated by screening for five mutant alleles (E297G, D482G, N591S, D676Y G855R) V444A polymorphism (c.1331T&gt;C, rs2287622) two cohorts (n = 333 UK, n 158 continental Europe), controls 261) V444A. PCR...

10.1136/gut.2008.159541 article EN Gut 2008-11-05

<b>Objectives</b> To evaluate current processes by which young children presenting with a febrile illness but suspected of having serious bacterial infection are diagnosed and treated, to develop test multivariable model distinguish infections from self limiting non-bacterial illnesses. <b>Design </b>Two year prospective cohort study. <b>Setting </b>The emergency department The Children's Hospital at Westmead, Australia. <b>Participants</b> Children aged less than 5 years between 1 July 2004...

10.1136/bmj.e3799 article EN cc-by-nc BMJ 2012-06-13

Intrahepatic cholestasis of pregnancy (ICP) is the most prevalent pregnancy-specific liver disease and associated with an increased risk adverse fetal outcomes, including preterm labor intrauterine death. The endocrine signals that cause are not known but 3α-sulfated progesterone metabolites have been shown to be elevated in ICP, leading us study impact sulfated on farnesoid X receptor (FXR)-mediated bile acid homeostasis pathways. Here we report 3β-sulfated metabolite epiallopregnanolone...

10.1002/hep.26055 article EN Hepatology 2012-09-07

A national UK workshop to discuss practical clinical management issues related pregnancy in women with myasthenia gravis was held May 2011. The purpose develop recommendations guide general neurologists and obstetricians facilitate best practice before, during after pregnancy. main conclusions were (1) planning should be instituted well advance of any potential allow time for myasthenic status drug optimisation; (2) multidisciplinary liaison through the involvement relevant specialists occur...

10.1136/jnnp-2013-305572 article EN Journal of Neurology Neurosurgery & Psychiatry 2013-06-11

Background Intrahepatic cholestasis of pregnancy (ICP) is a common disease affecting up to 5% pregnancies and which can cause fetal arrhythmia sudden intrauterine death. We previously demonstrated that bile acid taurocholate (TC), raised in the bloodstream ICP, acutely alter rate rhythm contraction induce abnormal calcium destabilization cultured neonatal rat cardiomyocytes (NRCM). Apart from their hepatic functions acids are ubiquitous signalling molecules with diverse systemic effects...

10.1371/journal.pone.0009689 article EN cc-by PLoS ONE 2010-03-12
Charaka Hadinnapola Marta Bleda Matthias Haimel Nicholas Screaton Andrew J. Swift and 95 more Peter Dorfmüller Stephen Preston Mark Southwood Jules Hernández‐Sánchez Jennifer M. Martin Carmen Treacy Katherine Yates Harm Jan Bogaard Colin Church Gerry Coghlan Robin Condliffe Paul A. Corris Simon Gibbs Barbara Girerd Simon Holden Marc Humbert David G. Kiely Allan Lawrie Rajiv D. Machado Robert Ross Shahin Moledina David Montani Michael Newnham Andrew J. Peacock Joanna Pepke‐Żaba Paula Rayner-Matthews Olga Shamardina Florent Soubrier Laura Southgate Jay Suntharalingam Mark Toshner Richard C. Trembath Anton Vonk Noordegraaf Martin R. Wilkins Stephen J. Wort John Wharton Stefan Gräf Nicholas W. Morrell Timothy J. Aitman David Bennett Mark J. Caulfield Patrick F. Chinnery Daniel P. Gale Ania Koziell Taco W. Kuijpers Michael Laffan Eamonn R. Maher Hugh S. Markus Willem H. Ouwehand David J. Perry F. Lucy Raymond Irene Roberts Kenneth G. C. Smith Adrian J. Thrasher Hugh Watkins Catherine Williamson Geoffrey Woods Sofie Ashford John R. Bradley Debra Fletcher Tracey Hammerton Roger James Nathalie Kingston Willem H. Ouwehand Christopher J. Penkett F. Lucy Raymond Kathleen Stirrups Marijke Veltman Timothy M. Young Sofie Ashford Matthew A. Brown Emma Clement John Davis Eleanor Dewhurst Marie Erwood Amy Frary Rachel Linger Sofia Papadia Karola Rehnström Hannah Stark David Allsup Steve Austin Tamam Bakchoul Tadbir K. Bariana Paula Bolton‐Maggs Elizabeth Chalmers Peter Collins Wendy N. Erber Tamara Everington Rémi Favier Kathleen Freson Bruce Furie Michael Gattens Keith Gomez Daniel Greene

Background: Pulmonary arterial hypertension (PAH) is a rare disease with an emerging genetic basis. Heterozygous mutations in the gene encoding bone morphogenetic protein receptor type 2 ( BMPR2 ) are commonest cause of PAH, whereas biallelic eukaryotic translation initiation factor alpha kinase 4 EIF2AK4 described pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis. Here, we determine frequency these and define genotype-phenotype characteristics large cohort patients...

10.1161/circulationaha.117.028351 article EN cc-by Circulation 2017-10-03
Coming Soon ...